October 27, 2017
Announcement of Phase 1 study results of Imarikiren (SCO-272) at the 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics383 KB
June 09, 2017
The presentations about the results of SCO-272 Ph1 trial in 54th ERA-EDTA
Press conference and Press releases about launch of SCOHIA PHARMA, Inc.